The Business Group on Health found 10% of currently-covering companies say they are unlikely to continue in 2027
Its ability to reduce weight significantly and improve metabolic health makes it a breakthrough therapy
This large cohort study used data on more than 145,000 people treated with GLP-1 agonists, and almost 292,000 people treated with DPP4 inhibitors from Norway, Sweden and Denmark
This is a major reason patients compare prescription GLP-1 vs compounded weight loss injections before starting treatment
Form: Pill Serving Size: 1 capsule daily Flavors: None Who is it best for
Secondary signals across both trials reduced knee osteoarthritis pain, fewer obstructive sleep apnea events, improvements in triglycerides, blood pressure, LDL, and hsCRP suggest systemic metabolic remodeling rather than simple caloric suppression